PPCB
Propanc Biopharma, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.44M
P/E Ratio
0.00
EPS
$52.11
Beta
3.52
52W High
$10.81
52W Low
$0.10
50-Day MA
$0.15
200-Day MA
$1.83
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Propanc Biopharma, Inc. Common Stock
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. The company is headquartered in Camberwell, Australia.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-65.10M |
| Operating Margin | 0.00% |
| Return on Equity | -1812.00% |
| Return on Assets | -536.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.78 |
| Price-to-Book | 0.23 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 2.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $21.86M |
| Float | $10.83M |
| % Insiders | 40.46% |
| % Institutions | 0.62% |
Historical Volatility
HV 10-Day
152.33%
HV 20-Day
113.48%
HV 30-Day
128.52%
HV 60-Day
149.07%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/20/2026